-
Group
BackGroupView
-
Who we are
BackWho we areView
- Profile
- Key figures
-
Governance
BackGovernanceView
-
Governance
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Our history
-
Who we are
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
What we do
BackWhat we doView
- At a glance
- Large Industries
- Industrial Merchant
- Healthcare
- Electronics
- Engineering & Construction
- Global Markets & Technologies
-
What we do
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Our strategy
BackOur strategyView
-
Our strategy
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Innovation
BackInnovationView
-
Research & Development
BackResearch & DevelopmentView
-
Research & Development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Digital transformation
-
Global markets & Technologies
BackGlobal markets & TechnologiesView
-
Global markets & Technologies
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Air Liquide Venture Capital
-
Innovation
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Research & Development
-
Sustainable development
BackSustainable developmentView
- Safety
-
Ethics
BackEthicsView
-
Ethics
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Human rights
- Climate objectives
- Environmental data
- Vigilance plan
- Extra-financial ratings
-
Stakeholders
BackStakeholdersView
-
Stakeholders
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Sustainable development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Where we operate
- Group publications
-
Group
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Who we are
-
Businesses
BackBusinessesView
-
Industry
BackIndustryView
-
Industry
-
Healthcare
BackHealthcareView
- Presentation
-
Our expertise
-
Our R&D
- Diseases
-
Public health challenges
BackPublic health challengesView
- Aging population
- Rise in chronic diseases
- Urbanization and lifestyle changes
- Reinventing the hospital
-
Public health challenges
-
Healthcare
-
Electronics
-
Engineering & Construction
BackEngineering & ConstructionView
-
Engineering & Construction
-
Science & New energies
BackScience & New energiesView
-
Science & New energies
-
Businesses
-
Industry
-
Magazine
BackMagazineView
- Industry of the future
- Healthcare
- Energy transition
- Customer experience
- Digitization
- Open innovation
- Science
-
Magazine
- Customers
-
Shareholders
BackShareholdersView
- Stock & Share: shareholders' mag
- Become a shareholder
-
Follow the Air Liquide share
BackFollow the Air Liquide shareView
-
Follow the Air Liquide share
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Factsheets
BackFactsheetsView
- Understanding the stock market
- Stock orders
- Shareholding options
- Registering shares
- Loyalty bonus
- Personal online Account
- Capital gains
- Free share attribution
- Dividend
- Taxation
- Passing on shares
-
Factsheets
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Shareholders' Communication Committee
- Annual General Meeting
- Agenda
-
Media library
BackMedia libraryView
-
Media library
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Contact us
-
Shareholders
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Investors
BackInvestorsView
- Agenda
- Documents & Presentations
- Vara consensus
-
Investing in Air Liquide
BackInvesting in Air LiquideView
-
Investing in Air Liquide
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Credit investor
BackCredit investorView
-
Credit investor
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Governance
BackGovernanceView
- Corporate officers remuneration and regulated commitments
- Board committees
- Capital and articles of association, Internal Regulations, disclosure of share buy-back transactions
-
Governance
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
- Regulated information
- Contact us
-
Investors
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Media
-
Careers
BackCareersView
- Job offers
- I choose Air Liquide
-
Careers at Air Liquide
BackCareers at Air LiquideView
-
Careers at Air Liquide
- Find our job offers
- Spontaneous application
-
You at Air Liquide
BackYou at Air LiquideView
-
You at Air Liquide
- Find our job offers
- Spontaneous application
- Students
-
Graduates
BackGraduatesView
-
Graduates
- Find our job offers
- Spontaneous application
Air Liquide expands its home healthcare business to Ireland
Air Liquide is expanding its home healthcare business in Europe with the acquisition of Baywater Healthcare Ireland Limited, a major player in this activity in Ireland.
On the Irish market for 30 years, Baywater Healthcare Ireland Limited specializes in treating and monitoring respiratory diseases in the patient's home (oxygen therapy, continuous positive airway pressure and non-invasive ventilation). Baywater Healthcare Ireland Limited has 50 employees and cares for 10,000 patients, generating revenue of more than €12 million in 2014.
This acquisition marks a new geographical development for Air Liquide's home healthcare business, with the extension of its services to Ireland. Air Liquide will continue growing the company with the support of the existing team.
Pascal Vinet, Vice-President, Healthcare Global Operations and member of Air Liquide group’s Executive Committee commented: "The acquisition of this company, which is recognized for its expertise in the treatment of respiratory diseases and for its culture of innovation, is part of Air Liquide's growth strategy for the home healthcare business. It will allow us to develop on a new growth market in Europe."
supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients.
In 2014, it served over 7,500 hospitals and 1,2 million patients at home throughout the world.
The Group’s Healthcare business reached € 2,570 million in revenues in 2014, with the support of its 12,000 employees.
Air Liquide, European leader in home healthcare, provides home healthcare services in compliance with medical prescription for patients suffering from chronic diseases such as COPD (Chronic Obstructive Pulmonary Disease), sleep apnea and diabetes. These home healthcare services are being developed in addition to hospital care, enabling patients to enjoy better quality of life and local authorities to reduce costs. Home healthcare represents 50% of Air Liquide's revenue in Healthcare in 2014.
© Air Liquide 2019